These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32615325)

  • 1. Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection.
    Garofoli F; Lombardi G; Angelini M; Campanini G; Zavattoni M; Baldanti F
    Int J Infect Dis; 2020 Sep; 98():150-152. PubMed ID: 32615325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.
    Choi KY; Sharon B; Balfour HH; Belani K; Pozos TC; Schleiss MR
    J Clin Virol; 2013 Aug; 57(4):356-60. PubMed ID: 23688863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study.
    Torii Y; Horiba K; Kawada JI; Haruta K; Yamaguchi M; Suzuki T; Uryu H; Kashiwa N; Goishi K; Ogi T; Ito Y
    BMC Infect Dis; 2022 Jun; 22(1):568. PubMed ID: 35733089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.
    Morillo-Gutierrez B; Waugh S; Pickering A; Flood T; Emonts M
    BMC Pediatr; 2017 Aug; 17(1):181. PubMed ID: 28830465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.
    Iwasenko JM; Scott GM; Rawlinson WD; Keogh A; Mitchell D; Chou S
    J Med Virol; 2009 Mar; 81(3):507-10. PubMed ID: 19152402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
    Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
    J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.
    Martin M; Goyette N; Ives J; Boivin G
    J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection.
    Boutolleau D; Deback C; Bressollette-Bodin C; Varnous S; Dhedin N; Barrou B; Vernant JP; Gandjbakhch I; Imbert-Marcille BM; Agut H
    Antiviral Res; 2009 Feb; 81(2):174-9. PubMed ID: 19063923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?
    Whitley RJ
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S60-S63. PubMed ID: 31205247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment in congenital HCMV infection: The six-year experience of a single neonatal center in Poland.
    Jedlińska-Pijanowska D; Czech-Kowalska J; Kłodzińska M; Pietrzyk A; Michalska E; Gradowska K; Dobrzańska A; Kasztelewicz B; Gruszfeld D
    Adv Clin Exp Med; 2020 Oct; 29(10):1161-1167. PubMed ID: 33053275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
    Leung PYM; Tran T; Testro A; Paizis K; Kwong J; Whitlam JB
    Transpl Infect Dis; 2019 Dec; 21(6):e13168. PubMed ID: 31498954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results.
    Cheng YC; Kang EY; Hwang YS; Hsiao CH
    Sci Rep; 2021 Feb; 11(1):3105. PubMed ID: 33542372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of prolonged valganciclovir therapy for congenital cytomegalovirus infection.
    Kashiwagi Y; Kawashima H; Nakajima J; Ishida Y; Nishimata S; Miyajima T; Takekuma K; Hoshika A; Inoue N
    J Infect Chemother; 2011 Aug; 17(4):538-40. PubMed ID: 21229284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
    Marsico C; Aban I; Kuo H; James SH; Sanchez PJ; Ahmed A; Arav-Boger R; Michaels MG; Ashouri N; Englund JA; Estrada B; Jacobs RF; Romero JR; Sood SK; Whitworth S; Jester PM; Whitley RJ; Kimberlin DW;
    J Infect Dis; 2019 Apr; 219(9):1398-1406. PubMed ID: 30535363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
    Boivin G; Goyette N; Gilbert C; Roberts N; Macey K; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N; Covington E
    J Infect Dis; 2004 May; 189(9):1615-8. PubMed ID: 15116297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
    J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.
    Dorfman L; Amir J; Attias J; Bilavsky E
    Eur J Pediatr; 2020 May; 179(5):807-812. PubMed ID: 31927626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.